Finance

Lists
PROK:NASDAQ
ProKidney Corp
$1.72
+0.58%
(+0.0100) 1D
$1.75
+1.74% (+0.030)
After hours
Closed: Oct 2, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PROK...
Open
$1.72
High
$1.74
Low
$1.66
Mkt. cap
519.99M
Avg. vol.
1.54M
Volume
1.09M
52-wk high
$3.48
52-wk low
$1.30
EPS
-$0.55
Beta
1.78
Shares outstanding
208.93M
No. of employees
231
Open
$1.72
High
$1.74
Low
$1.66
Mkt. cap
519.99M
Avg. vol.
1.54M
Volume
1.09M
52-wk high
$3.48
52-wk low
$1.30
EPS
-$0.55
Beta
1.78
Shares outstanding
208.93M
No. of employees
231
News stories
From web sources and news partners
About ProKidney Corp
CEO-
Employees231
Founded2015
HeadquartersWinston-Salem, North Carolina, United States
SectorBiotechnology
Websiteprokidney.com
Analyst ratings
Based on 5 analysts giving stock ratings to PROK in the past 3 months
Hold
Buy
2
Hold
2
Sell
1
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for PROK in the last 3 months.
Highest
Current $1.72
$12.00 (+597.67%)
Average
$5.75 (+234.30%)
Lowest
$1.00 (-41.86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Anupam Rama
J.P. Morgan
Hold
Maintained
-
-
08/13/2026
Judah Frommer
Morgan Stanley
Hold
Maintained
$3.00
+74.4%
08/11/2026
Unknown Analyst
Guggenheim
Buy
Maintained
$7.00
+307%
08/10/2026
Joseph Pantginis
H.C. Wainwright
Buy
Maintained
$12.00
+597.7%
08/11/2026
Dina Ramadane
Bank of America Securities
Sell
Reiterated
$1.00
-41.9%
08/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
217.00K
225.00K
226.00K
150.00K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
26.82M
34.16M
33.84M
36.10M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11.62M
11.76M
11.32M
12.43M
Operating expense
38.44M
45.91M
45.16M
48.52M
Total operating expenses
38.44M
45.91M
45.16M
48.52M
Operating income
-38.22M
-45.69M
-44.93M
-48.37M
Other non operating income
-
-
-
-
EBT including unusual items
-35.28M
-42.44M
-42.62M
-46.44M
EBT excluding unusual items
-34.96M
-42.76M
-42.62M
-46.44M
Income tax expense
560.00K
-1.58M
-
-
Effective tax rate
-1.59%
3.73%
-
-
Other operating expenses
-
-
-
-
Net income
-16.47M
-19.23M
-20.04M
-28.42M
Net profit margin
-7,589.40%
-8,547.11%
-8,865.93%
-18,948.00%
Earnings per share
-0.12
-0.14
-0.14
-0.15
Interest and investment income
3.26M
2.94M
2.33M
1.94M
Interest expense
-2.00K
-1.00K
-15.00K
-1.00K
Net interest expenses
3.26M
2.93M
2.31M
1.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
-36.55M
-43.85M
-43.28M
-46.70M
Gain or loss from assets sale
10.00K
957.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps